Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

Presentation TCT 2025

Pearls and Pitfalls of Left Main PCI

Presenter: Duk-Woo Park

October 28, 2025

Presentation TCT 2025

Provisional Left Main Stenting: Contemporary Considerations

Presenter: Duk-Woo Park

October 28, 2025

Presentation TCT 2025

High risk / CTO PCI with use of Cangrelor

Presenter: Duk-Woo Park

October 28, 2025

Presentation TCT 2025

When to Act and When to Wait: Managing High-Risk Plaques and Patients

Presenter: Duk-Woo Park

October 27, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

Presenter: Duk-Woo Park

October 26, 2025

Presentation ESC 2025

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Presenter: Duk-Woo Park

August 31, 2025

Podcast TCTMD Talking Points

The EPIC-CAD Trial

July 02, 2025

Presentation TCT 2024

Pro

Presenter: Duk-Woo Park

October 28, 2024

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Todd Neale

September 01, 2024

News Daily News

Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials

Todd Neale

July 10, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

DAPT Duration: Unsettled or Case Closed?

Presenter: Duk-Woo Park

October 24, 2023

Presentation ESC 2023

Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided PCI: The OCTIVUS Randomized Clinical Trial

Presenter: Duk-Woo Park

August 28, 2023

News Conference News ESC 2023

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

Shelley Wood

August 27, 2023

Podcast TCTMD Talking Points

The ADAPT-TAVR Trial

March 08, 2023

News Conference News ESC 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Yael L. Maxwell

September 06, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

Advertisement

Pearls and Pitfalls of Left Main PCI

Provisional Left Main Stenting: Contemporary Considerations

High risk / CTO PCI with use of Cangrelor

When to Act and When to Wait: Managing High-Risk Plaques and Patients

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

The EPIC-CAD Trial

Pro

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

DAPT Duration: Unsettled or Case Closed?

Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided PCI: The OCTIVUS Randomized Clinical Trial

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

The ADAPT-TAVR Trial

Routine Functional Testing Unnecessary After Stenting: POST-PCI

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content